The European Conference on Neonatal and Paediatric Pulmonary Vascular disease invites you to join the 6th edition of the conference. After 5 successful past editions, the latest developments in field of pulmonary vascular disease will be presented 9, 10 & 11 October 2024
EBAC Accreditation Approved
The European Conference on Neonatal and Paediatric Pulmonary Vascular disease 2024 (PPVD) has now been officially accredited by the European Board for Accreditation in Cardiology (EBAC).
​
In compliance with EBAC guidelines, all speakers/ chairpersons participating in this program have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. The Organizing Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CE activities.
Pre-conference symposium, fully dedicated to the TBX4-syndrome​
​
We invite you to the first in-person TBX4-syndrome symposium, co-organized with TBX4Life. TBX4Life is an international consortium uniting clinicians, scientists, patients and families in the quest for a cure of the TBX4 syndrome, a multifaceted disease affecting infants, children and adults, emerging as one of the most prevalent causes of heritable pulmonary hypertension. This symposium brings together scientists, neonatologists, pediatricians, cardiologists, pulmonologists, intensivists, nurses and other interested actors, with the goal of raising awareness, sharing knowledge, advancing research and shaping the future of care for the TBX4 syndrome. You are warmly invited to participate and submit cases to be discussed during the round table session.